Cartesian Therapeutics
RNAC
#8755
Rank
NZ$0.27 B
Marketcap
NZ$10.50
Share price
-8.19%
Change (1 day)
-69.12%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2025 (TTM): -NZ$0.13 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are NZ$1.09 Million. In 2024 the company made an earning of -NZ$45.38 Million, an increase over its 2023 earnings that were of -NZ$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.13 Billion183.03%
2024 -NZ$45.38 Million-88.5%
2023 -NZ$0.4 Billion-724%
2022 NZ$63.21 M-649.67%
2021 -NZ$11.51 Million-89.78%
2020 -NZ$0.12 Billion25.06%
2019 -NZ$90.03 Million-15.68%
2018 -NZ$0.11 Billion-0.43%
2017 -NZ$0.11 Billion83.41%
2016 -NZ$58.46 Million44.3%
2015 -NZ$40.52 Million